Skip to main navigation Skip to search Skip to main content

A Phase 3, Double-Blind, Randomised, Long Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholoic Acid in Subjects with Nonalcoholoic Steatohepatitis

Project: Research

Project Details

StatusActive
Effective start/end date05/3/16 → 12/31/26

Funding

  • Intercept Pharmaceuticals Incorporated: $622,943.63